ad image

Company Info

iBio, Inc.

iBio, Inc.

CDMO

Overview

iBio is an innovator biologics company developing therapeutics and vaccines for the betterment of human and animal health with pipeline candidates targeting systemic sceleroderma (IBIO-100), COVID-19 (IBIO-200 and IBIO-201), and classical swine fever (IBIO-400). iBio’s subsidiary, iBio CDMO is a global leader in plant-based manufacturing. Its FastPharming® and FastGlycaneering™ platforms provide contract development and manufacturing services via its 130,000 square foot facility in Bryan, Texas. The speed and scalability of FastPharming make it an ideal choice for other innovator companies who want to rapidly produce biologics.
iBio, Inc.
Contributions
19 Contributions1 / 1
Unlocking New Possibilities with FastPharming
Plant-Based Expression

Unlocking New Possibilities with FastPharming

Tom Isett; Randy Maddux

iBio, Inc.

PAO-05-22-R250-03May 11, 2022
Changing the Paradigm of Cancer Drug Discovery and Development with Plants
Oncology

Changing the Paradigm of Cancer Drug Discovery and Development with Plants

Martin Brenner, DVM, Ph.D.; Randy Maddux; Steven King

iBio, Inc.

PAO-02-022-CL-02Mar 12, 2022
Quality Plant-Made mAbs with FastPharming®

Quality Plant-Made mAbs with FastPharming®

Sopheap Sun, MBA; Rachel Jordan, Ph.D.; Courtney McGee, M.S.

iBio, Inc.

PA607Mar 10, 2022
iBio, Inc.
COVID-19 Vaccine

iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program

iBio, Inc.

PR-M05-21-005May 07, 2021
The Advantages of Implementing Plant-Based Vaccines
Vaccine Development

The Advantages of Implementing Plant-Based Vaccines

Sylvain Marcel, Ph.D; Robert Erwin; Brian R. Berquist, Ph.D.

iBio, Inc.

PAP-Q3-20-CL-021Sep 29, 2020
Applying Rapid Countermeasure Preparedness to Development of a Novel COVID-19 Vaccine
COVID-19 Vaccine

Applying Rapid Countermeasure Preparedness to Development of a Novel COVID-19 Vaccine

Sylvain Marcel, Ph.D; Robert Erwin; Brian R. Berquist, Ph.D.; Tom Isett

iBio, Inc.

PAO-M04-20-CL-002Apr 23, 2020
iBio, Inc.
Vaccine

iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute

iBio, Inc.

PR-M04-20-NI-015Apr 09, 2020
iBio, Inc.
COVID-19 Vaccine

iBio Announces Advancement of COVID-19 Vaccine Program

iBio, Inc.

PR-M04-20-NI-013Apr 07, 2020
iBio, Inc.
Biosecurity

iBio Joins the Alliance for Biosecurity

iBio, Inc.

PR-M03-20-NI-038-1641Mar 23, 2020
iBio, Inc.
COVID-19 Vaccine

iBio Announces Development of Proprietary COVID-19 Vaccine Candidates

iBio, Inc.

PR-M03-20-NI-037-1642Mar 23, 2020
Facilitating 3D Organ Printing with Plant-Based BioInks
3D Bioprinting

Facilitating 3D Organ Printing with Plant-Based BioInks

Sylvain Marcel, Ph.D; Robert Erwin; Brian R. Berquist, Ph.D.; Tom Isett

iBio, Inc.

PAP-Q4-19-CL-018Dec 06, 2019
iBio, Inc.
Collaboration

iBio’s Collaboration with South Africa’s AzarGen Biotechnologies Advances to Next Stage

iBio, Inc.

PR-M09-19-NI-048Sep 20, 2019
iBio, Inc.
Collaboration

iBio and CC-Pharming Expand Business Collaboration in China

iBio, Inc.

PR-M08-19-NI-087Aug 26, 2019
iBio, Inc.
3D Bioprinting

iBio Inks 3D Bioprinting Agreement

iBio, Inc.

PR-M08-19-NI-058Aug 20, 2019
FastPharming for Speed to Market
Speed to Market

FastPharming for Speed to Market

iBio, Inc.

PTV-M08-19-BIO-008Aug 12, 2019
Reducing Fill-Finish Wait Times
Fill-Finish

Reducing Fill-Finish Wait Times

Brian R. Berquist, Ph.D.

iBio, Inc.

PAO-NI-0719-CL-003Jul 25, 2019
iBio, Inc.
Fill/Finish Agreement

iBio Announces First Agreement for Fill-Finish Services

iBio, Inc.

PR-M06-19-NI-033Jun 20, 2019
The Advantage of Plant-Based Expression Solutions Around the Globe
Plant-Based Innovation

The Advantage of Plant-Based Expression Solutions Around the Globe

Sylvain Marcel, Ph.D; Robert Erwin

iBio, Inc.

PAO-M05-19-CL-002May 30, 2019
Plant-based Protein Expression for Rapid, Green Bioprocessing
Plant-Based Solutions

Plant-based Protein Expression for Rapid, Green Bioprocessing

Robert Erwin

iBio, Inc.

PAP-Q2-2019-CL-022May 24, 2019
1 / 1